Stay updated on Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a minor update to the page's metadata.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated from v3.5.2 to v3.5.3, representing a small version metadata update to the study record.SummaryDifference0.0%

- Check37 days agoChange DetectedUpdated the ClinicalTrials.gov page revision indicator from **v3.5.0** to **v3.5.2**.SummaryDifference0.0%

- Check66 days agoChange DetectedAdded Naples, Italy 80131 to the location list and removed Napoli, Italy 80131; updated Revision from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check80 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check103 days agoChange DetectedRevision labels updated: Revision v3.4.2 added and Revision v3.4.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page.